Antibiotics are a double-edged sword – they must be harmless to the cells of the human body, as well as as toxic as possible to pathogenic bacteria. An international research team led by the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has now developed a drug that achieves precisely that. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.
